Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiq… Read more
Aoxing Pharmaceutical Company Inc (AOXG) - Total Liabilities
Latest total liabilities as of March 2017: $44.38 Million USD
Based on the latest financial reports, Aoxing Pharmaceutical Company Inc (AOXG) has total liabilities worth $44.38 Million USD as of March 2017.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Aoxing Pharmaceutical Company Inc - Total Liabilities Trend (2001–2016)
This chart illustrates how Aoxing Pharmaceutical Company Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Aoxing Pharmaceutical Company Inc Competitors by Total Liabilities
The table below lists competitors of Aoxing Pharmaceutical Company Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jubilant Flame International Ltd
OTCQB:JFIL
|
USA | $1.41 Million |
|
Wingara AG Ltd
AU:WNR
|
Australia | AU$1.31 Million |
|
ADMIRAL GROUP - Dusseldorf Stock Exchang
DU:FLN
|
Germany | €6.63 Billion |
|
Global Bioenergies SA
F:1DK
|
Germany | €7.96 Million |
|
Ready Set Gold Corp
PINK:RDYFF
|
USA | $4.26 Million |
|
Hydrocarbon Dynamics Limited
PINK:PYMOF
|
USA | $436.69K |
|
BANKUNITED
BE:BNU
|
Germany | €32.98 Billion |
|
Birman Wood and Hardware Ltd
TA:BIRM
|
Israel | ILA213.61 Million |
Liability Composition Analysis (2001–2016)
This chart breaks down Aoxing Pharmaceutical Company Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aoxing Pharmaceutical Company Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aoxing Pharmaceutical Company Inc (2001–2016)
The table below shows the annual total liabilities of Aoxing Pharmaceutical Company Inc from 2001 to 2016.
| Year | Total Liabilities | Change |
|---|---|---|
| 2016-06-30 | $38.16 Million | -11.22% |
| 2015-06-30 | $42.98 Million | +2.13% |
| 2014-06-30 | $42.08 Million | +19.73% |
| 2013-06-30 | $35.15 Million | +47.53% |
| 2012-06-30 | $23.82 Million | +18.15% |
| 2011-06-30 | $20.16 Million | -16.05% |
| 2010-06-30 | $24.02 Million | -25.18% |
| 2009-06-30 | $32.11 Million | +3.69% |
| 2008-06-30 | $30.96 Million | +67.56% |
| 2007-06-30 | $18.48 Million | +37.28% |
| 2006-06-30 | $13.46 Million | +1895.02% |
| 2005-06-30 | $674.72K | -42.03% |
| 2003-06-30 | $1.16 Million | -15.47% |
| 2002-06-30 | $1.38 Million | -7.34% |
| 2001-06-30 | $1.49 Million | -- |